AMSilk
AMSilk is the world's first industrial supplier of smart biotech materials with current scale-up phase by applying an outstanding technology protein platform based on silk proteins for a variety of applications such as textile fibers, medical devices and consumer goods.
AMSilk has raised €77M across 2 funding rounds from 6 investors, most recently a round in Sep 2025. Based in Munich, Germany; active in Healthtech. Data as of 28 Oct 2026.
Munich, Germanywww.amsilk.com ↗
Total raised
€77M
€77,000,000
Funding rounds
2
Investors
6
distinct backers
Active since
2023-04
latest 2025-09
Funding by year
EUR raised per yearAMSilk — funding by year — interactive chart.
Data table
| AMSilk — funding by year | |
|---|---|
| 2023 | €25M |
| 2025 | €52M |
Signals
High confidenceRaise-next likelihood47
base rate 30% for Other
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood18
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▲ Recently backed by strong-exit-track investors
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-09-09 | Other | €52M | Athos Capital,MIG Capital,Novo Holdings | View deal → |
| 2023-04-04 | Series C | €25M | Athos Capital,Cargill,MIG Capital,MIG Capital,Novo Holdings | View deal → |
Related news
Similar companies
same sector or country- Delivery Hero€7.1BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Helsing€2.9BGermany · AI
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
Global coverage: FundingData